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Abstract
In the past, obtaining accurate medical diagnoses often necessitated surgery,
required expensive diagnostic tests, or was completely unattainable.

Additionally, the

treatments of many medical conditions demanded highly invasive procedures that were
frequently ineffective and unsuccessful. With modern developments in Positron Emission
Tomography (PET), however, the medical world is becoming revolutionized.
My involvement in PET innovations focused mainly on the development of a new PET
scanner at CTI PET Systems, Inc., located in Knoxville, TN. This scanner is original due to
its ability to provide greater image resolution, less scanning time, and automated source
strength correction.

The three major areas of my work included the Coincidence Point

Source Interface, the Smart Source Board, and the Smart Source Testware.
My greatest learning experience and most significant contribution to CTI's new PET
scanner was the Smart Source Testware development.

This task required me to write

programs in Microsoft Visual C++, a language I had never used prior to this project. I also
learned to read and write EEPROMs for the first time. The Smart Source Testware can be
used for other applications in CTI PET scanners as well. My code is well documented and
can easily be modified for use in new aSSignments with similar requirements.
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2

Introduction
During the summer of 2001, I worked as an engineering intern at CTI PET Systems,
Inc. My main tasks involved electrical and computer design work for a new Positron
Emission Tomography (PET) prototype. Since my academic major and interests are
within the field of Nuclear Engineering (concentrated in Radiological Engineering), I
wanted to continue this type of work for my Senior Honors Project. This project was
supervised by engineers and management at CTI PET Systems, Inc. and by Dr.
Harold L. Dodds.

3

Positron Emission Tomography
In the past, obtaining accurate medical diagnoses often necessitated surgery,
required expensive diagnostic tests, or was completely unattainable. Additionally, the
treatments of many medical conditions demanded highly invasive procedures that
were frequently ineffective and unsuccessful. With modern developments in Positron
Emission Tomography (PET), however, the medical world is becoming revolutionized.

3.1

What is PET?
PET is an emerging non-invasive, diagnostic imaging technique used for measuring
the metabolic activity of cells in the human body. It is approved by many insurance
carriers and used by physicians to diagnose and manage patient treatment plans for
numerous diseases.
Traditional diagnostic techniques, such as x-rays, computed tomography (CT) scans,
or magnetic resonance imaging (MRI), produce images of the body's anatomy or
structure. The premise with traditional techniques is that disease causes a change in
structure or anatomy that can be observed.
images of the body's basic biochemistry.

PET is unique because it produces

These biochemical processes may be

altered by disease before there is a change in anatomy.

For example, even in

diseases such as Alzheimer's, where there is initially no gross structural abnormality,
PET is able to show a biochemical change.
In addition to imaging and measuring metabolic processes, there are other reasons
that PET is a vital addition to the clinician's diagnostic toolbox.
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PET can validate

and/or modify patient management and care. Furthermore, it reduces patient risk and
improves patient outcome.

Lastly, PET decreases overall healthcare costs and

defines appropriate pathways of medical care.

3.2

PET Applications
PET's uniqueness and value lie in its ability to quantitatively measure biochemical,
metabolic, and functional activity in well defined, localized regions of the body. PET
is primarily used in cardiology, neurology, and oncology.

Specifically, it can be

utilized to access the benefit of coronary artery bypass surgery, identify causes of
childhood seizures and adult dementia, and detect and classify tumors (CTI PET
Systems Patients' Info).

3.2.1 Cardiology
PET has several promising clinical applications among patients with known or
suspected heart ailments.

PET allows physicians to screen for coronary artery

disease and to assess flow rates and flow reserve.

It has also proven useful in

distinguishing viable from nonviable myocardium tissue - knowledge which can be
used to predict the therapeutic success of a cardiology patient after undergoing
bypass, angioplasty, or transplant procedures.

3.2.2 Neurology
PET provides information for evaluating numerous neurological diseases such as
Alzheimer's and other dementias, Parkinson's, Huntington's, and Down's Syndrome.
Additionally, it offers assistance to epilepsy patients by localizing epileptic foci in order
to qualify and identify the site for surgical intervention.

It also enables the

characterization, grading, and assessment of possible brain tumor recurrence.

3.2.3 Oncology
PET is the only modality that can accurately image many organs of the body with a
single pass to allow discrimination between benign and malignant tissues. It can also
provide information to determine whether a primary cancer has metastasized to other
parts of the body.

PET has demonstrated its usefulness in the early detection of

recurrent tumors, grading of existing tumors, and the selection and evaluation of
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therapy treatments.

PET offers further assistance in the following ways: providing

whole-body metastatic surveys, avoiding biopsies for low grade tumors, differentiating
tumors from radiation necrosis non-invasively, determining the need for early change
in course of ineffective chemotherapy, and avoiding unnecessary diagnostic and
therapeutic surgeries. PET has proven a high degree of accuracy for determining the
presence or spread of many malignant tumors including: lung cancer, ovarian cancer,
breast cancer, lymphomas, head/neck tumors, colorectal cancer, melanoma, brain
tumors, and pancreatic cancer .

•

•

Mol. body PET scan 01 patiflllt
with nult.static disease

Figure 3.2. PET Image Used in Oncology

3.3

How Does PET Work?
The PET scan is a simple procedure involving the use of a small amount of a short
half-lived radiopharmaceutical (produced by a cyclotron or generator), comparable to
the amount used in other nuclear medicine procedures.

A radioactive element is

incorporated into a compound that is familiar to the body, such as glucose, water,
ammonia, or certain drugs. The radioactive compound is then administered to the
patient, usually by injection, and a specially designed PET scanner images how the
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body processes the introduced material.

The radiopharmaceuticals discharge

positrons from wherever they are located in the body. As these positrons encounter
elements within the body, gamma rays are produced from resulting reactions.
A patient preparing to undergo a PET scan must first lie on a table that slides into the
middle of the scanner (see Figure 3.3.1). Inside the scanner are rings of detectors
constructed with special crystals that produce light when struck by a gamma ray. The
internal electronics of the scanner record the detected gamma rays and map an
image of the area where the radiopharmaceutical is located.

Because the

radiopharmaceutical contains a chemical that is regularly used by the body, PET
enables a physician to see the location of the metabolic process.

For example,

glucose (a sugar which the body uses to produce energy) combined with a
radioisotope shows where glucose is being utilized in the brain, the heart muscle, or a
growing tumor (CTI PET Systems Patients' Info).

Figure 3.3.1. CTI ECAT® Tomograph (PET Scanner)

In summary, a PET patient receives an intravenous injection of a radioactive tracer.
The radioactive compound is then distributed throughout the body and processed by
the organs being studied. The PET scanner records the position of the tracer as the
emitted positrons interact with electrons in the body (positron annirlilation), creating
gamma radiation that can be detected by detectors outside the body. A computer
reconstructs the pattern of detected radioactivity into three-dimensional pictures of the
body.
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Figure 3.3.2. PET Image of Upper Body

3.4

PET Cost Effectiveness
PET is responsible for improved accuracy in diagnosis, avoidance of unnecessary

surgeries, and significant savings for surgeries not performed. Gambhir et al report
that the use of both PET and CT scans provides a savings of $1154 per patient over
the use of the CT scan alone (1432).
The ICP Cardiology Task Force contends that the myocardial viability assessment is
more accurate with PET than with the Thallium stress test. They note that PET is
capable of screening out patients without viable tissue who would not benefit from
surgery. Such knowledge has allowed the number of unnecessary catheterizations to
reduce by 280/0 and the number of unnecessary CABGs (Coronary Artery Bypass
Grafting) to reduce by 12%. Fewer surgeries ultimately result in a reduction in the
number of potential post-surgical complications. Lastly, PET is useful in determining
viable candidates for cardiac transplants (ICP Cardiology Task Force).

4

eTI PET Systems, Inc.
CTI is the leading supplier of products and services for the Positron Emission
Tomography market.

CTl's product line includes the RDS cyclotron products, the

RDS chemical synthesis units, and the ECA~ tomograph (i.e., PET scanner)
products.

Cyclotrons are particle accelerators that generate positron emitting

isotopes. The chemical synthesis units incorporate these isotopes into radiolabeled
compounds which, through injection or inhalation, are taken up in body tissue in
proportion to biochemical activity. A scanner then detects this radiation emitted from
positron decays and forms images of the labeled compound distribution. Together
they work to provide significantly more valuable diagnostic information for physicians
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compared to conventional anatomical imaging techniques. CTI also provides other
PET-related products and services, including the distribution of selected PET
compounds in major metropolitan areas.

5

Project Outline
My involvement in CTrs PET innovations was focused mainly on the development of
a new PET scanner, currently termed the "P39 Project."

The electronics and

programming involved with this project are extremely complicated and require the
combined efforts of the entire Research and Development department at CTI.

I

contributed to a small portion of this network by focusing on an electronic board
termed the "Coincidence Point Source Interface" and an EEPROM (Electrically
Erasable Programmable Read Only Memory) chip termed the "Smart Source". This
report only includes the results of my research and contributions since most of the
other components of the P39 Project have yet to be completed.

The three major

areas of my work include the Coincidence Point Source Interface, the Smart Source
Board, and the Smart Source Test Hardware/Software.

5.1

PET Transmission Overview for the P39 Project
In addition to collecting emission data by detecting gamma radiation produced within
a patient who has received a radiopharmaceutical injection, transmission data must
also be collected to correct a large source of error in the emission data. This error is
caused by the attenuation of gamma radiation within the body or entity being
measured. This means that some gamma radiation will interact with elements within
the body, and thus, will never reach a detector. The radiation that does not interact
with a detector is not accounted for unless physicians are able to determine the
number of gammas that are typically "lost" to interactions within the body.

By

accurately measuring the gamma radiation attenuation, a simple normalization can be
made to correct the acquired emission data for a given attenuation.
The P39 transmission source will utilize a transmission system in which a point
source is loaded with a positron isotope (either 68Ge or 22Na), and ten of these point
sources will be loaded into a Point Source Assembly (Overbay). When an isotope
within a point source emits a positron, positron annihilation will occur as soon as the
positron combines with an atomic electron.
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As positron annihilation occurs, two

0.511-MeV gamma photons are emitted 180 degrees from one another. In order to
insure that only the annihilation photons are counted, two detectors are placed 180
degrees apart. A high-speed detector is placed adjacent to the source in order to
collect one of the gamma photons produced by the positron annihilation. Fast signal
processing electronics record these detector events and perform coincidence
measurements. Coincidence measurements include only those events in which the
two annihilation gammas are detected simultaneously within their respective
detectors.

If the detector that is adjacent to the source detects an annihilation

gamma, but the second detector does not, the undetected gamma photon has most
likely been attenuated within the body.
This system has the ability to acquire emission and transmission data concurrently,
which permits better registration of emission and transmission data since there is less
opportunity for a patient's body to shift between the transmission and emission
acquisitions.

5.2

Definitions
Smart Source

Dallas Semiconductor EEPROM which enables
the storage of activity and manufacture date for
each of the ten pOint sources

Smart Source Board

Small pc-board to which Smart Source EEPROM
is mounted

Point Source Assembly

Assembly containing all components of the point
source mechanism; includes a rod with ten
windows, ten pOint sources and photomultiplier
tubes, sensors, motor, and Smart Source Board

Coincidence Point Source
Interface

Interface board between the Smart Source Board
and the Detector Head Interface; use of several
connectors

Detector Head Interface

Board that communicates with the Coincidence
Point Source Interface and reads the Smart
Source contents
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5.3

6

Acronyms and Abbreviations
BOM

Bill of Materials

CPSI
CRC
DHI
ECAT

Coincidence Point Source Interface Board

Emission Computerized Axial Tomography

EEPROM

Electrically Erasable Programmable Read Only Memory

ESD

Electrostatic Discharge

PET

Positron Emission Tomography

PMT
PSA
SSB

Photomultiplier Tube

Smart Source Board

SS

Solid State (Relays)

UDP

Universal Data Packet

Cyclic Redundancy Check
Detector Head Interface

Point Source Assembly

Coincidence Point Source Interface
This section describes the initial specifications that I wrote for the P39 Project
Coincidence Point Source Interface board. The Coincidence Point Source Interface
board (CPSI) provides communication between the detectors, Point Source Assembly
(PSA) motor and sensors, power supplies, and detector electronics of the P39 PET
scanner. The CPSI resides adjacent to the PSA.

6.1

Functionality
The CPSI provides convenient connection points for power, detectors, signal cables
to the detector electronics, motor, and motion sensors. It provides high voltage for
the photomultiplier tubes (PMTs), and the CPS I has preamplifiers for each PMT
output. Two relays on the CPSI are responsible for switching the 220 VAC to the
motor on the PSA. When the relay circuits close, current flows to the PSA motor in
order to drive it forward. As the motor rotates, it extends the PSA point source rod
outward using a "rack and pinion" drive, until a mechanical stop is reached (each of
the ten point sources is aligned with its respective window at this point). The outward
movement of the rod causes a powerful spring, attached to the rod assembly, to
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stretch and gain tension.

Once rod motion ceases, the motor stalls while data is

being collected since it is still receiving power (the proposed motor can stall
indefinitely without resulting in damage or burn-up).

After all data collection is

complete, the relay circuits open and terminate current flow to the motor. The spring
begins to recoil as soon as the motor loses power, and as a result, it drives the motor
backwards. This reverse drive causes the rod to retract to its original position such
that the point sources are no longer exposed.

The electronics assembly mounts

within the cover of the PSA mechanical assembly.

Smart Source .---------------------------~7. EEPROM 1/0
EEPROM
Source Extended
r - - - - - - - - - - - - - - - - - - - - - - - - - i ' Source Retracted
Motor "On" Signal

+5V
GND
-5.2 V

~+12V

Laser Module

Laser Module

~
Point Source :
PMT A
.----VPreamPlifier
Point Source :
~
PMT B
4-----[/preamPlifier
Point Source :
~
PMT C
.----vPreamplifier
Point Source :
~
PMT D
4-----vPreamplifier
Point Source
PMT

.------1
ToDHI

Point Source 4 - - - - - - 1
PMT F
Point Source
PMTG

.------1

Point Source
PMTH

.------1

Point Source :
~
PMT I
4-----~reamplifjer
Point Source 4 - - - - - - 1
PMT J

Figure 6.1

Block Diagram of Coincidence Point Source Interface Board
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6.2

Components
The CPSI contains several electrical components, and the descriptions of the
preamplifiers and relays are discussed below.

6.2.1 Preamplifiers
The PMTs of the PSA have to run at a low gain. This is due to the high count rates
expected as a result of the detector proximity to the point source. Considering this
count rate and the overall light output from the detector crystal, low PMT gain is the
only way to avoid damaging high average anode current in the tube (Moyers).
Because of the low PMT gain, preamplification is required to boost the signals to
levels required by the analog processor. The preamplifier circuit will be a simple oneor two-stage (depending on the gain needed) current feedback operational amplifier
design. The amplifier gains have yet to be determined. A delay line may be required
to correct for the short time of flight of the PSA PMTs. Output is differential, reducing
noise at the analog processor. The block diagram of the preamplifier/delay circuit is
shown in Figure 6.2.

PMT
Input

Output

Figure 6.2. PMT Preamplifier/Delay Circuit

6.2.2 Relays
Two Solid State (SS) single pole relays will be used on the CPSI to control current
flow to the PSA motor. Once the relays receive an enabling signal from the Detector
Head Interface (DHI), the relay circuits will close allowing current to flow to the motor.
The relays will have an input of 220 VAC. They are paired for redundancy purposes
if one fails, opening one leg of the motor power will still allow the sources to retract.
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6.3

Risk Assessment & Hazard Analysis
A comprehensive Risk Assessment and Hazard Analysis will not be considered at this
level unless an assembly or subassembly analysis shows that it is warranted. High
voltage is not present on the board, and no board components are high current.
Therefore, the risk of fire is minimal on the CPSI.

6.4

Initial Production, Verification, & Validation

6.4.1 Initial Production
Initial Production Units of the CPSI will be built prior to Release to Production of the
Coincidence Point Source Interface assembly.

These units will be assembled by

Benchmark Electronics. The Responsible Engineer will be accountable for testing the
units built prior to Release to Production.

All documentation pertaining to the

assurance of these units' functionality will be retained in the Coincidence Point
Source Interface design notebook. Changes to the initial design will be documented
in the P39 project notebook.

6.4.2 Verification
At least six units will be built first.

These units will be visually inspected for

consistency to the schematics and bill of materials (BOM). All power connections will
then be checked for shorts with an ohmmeter.

The unit will be powered on the

bench, and desired operation of all circuits will be verified and documented.

6.4.3 Validation
Validation of the assembly will be performed through integration with the detector
panel and the detector electronics. The detectors are assembled and attached to the
Detector Panel Interface board, which is connected to the detector electronics.
System

setups

will

be

performed,

detector/electronics documented.
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and

the

performance

of

the

overall

6.5

Additional Requirements

6.5.1 Labeling & Packaging Requirements
All boards will have CTI part numbers, serial numbers, and revision levels clearly
marked.

They will be handled and shipped according to the usual Electrostatic

Discharge (ESD) precautions.

6.5.2 Environmental Limitations
The CPSI will be enclosed in the gantry. which is sealed and environmentally
controlled.

6.5.3 Applicable Standards & Regulatory Requirements

6.6

•

European Union Medical Device Directive (MDD), 12 July 1993, 93/42/EEC.

•

Quality System Regulation, 21 CFR Part 820 Medical Devices; Current Good
Manufacturing Practice (CGMP).

•

ANSIIASQC Q9001-1994 (ISO) Quality Systems Model for Quality Assurance in
Design, Development, Production, Installation, and Servicing.

•

IEC 601-1-4, Medical Electrical Equipment - General Requirements for Safety.

Cost Goal
Each Coincidence Point Source Interface Board will cost approximately $300 to build.

6.7

Tentative Schedule
TASK

Du ration (days)

Develop the P39 CPSI Board
Initial Specifications
Design
Schematics
Choose Parts I Create BOM
Design Review
P39 CPSI Board Layout
PCB Placement/Routing
Placement/Routing Review
P39 CPSI Board Verification
Verify six boards
Develop ValidationlT est Procedure
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25
2
13

5
3
2

14
13
1

10
5
5

7

Smart Source Board
This section describes the initial specifications that I wrote for the P39 Project Smart
Source Board. The Smart Source Board (SSB) connects to the CPSI to relay source
strength information to the Detector Head Interface. The SSB stores source strength
and other general information in an EEPROM, and it connects to the CPSI via a
flexible cable.

7.1

Functionality
The P39 system will employ positron isotopes for radiation sources. These positronemitting isotopes suffer from relatively short half-lives of either 0.740 years (for 68Ge)
or 2.66 years (for 22Na).

This diminishing source activity can lead to errors in

quantification in PET scanning if not accounted for.

Thus, it is important that the

transmission sources be replaced at regular intervals to ensure adequate isotope
activity to support quality transmission imaging.

Present coincidence transmission

systems lack an automated way to account for source activity each time the sources
are changed. When new sources are placed in the tomograph, a manual notation
must be made of the source manufacture date and activity of each source.

This

burden would be significant while trying to maintain the twenty different sources of the
two P39 point source assemblies.
In order to determine when the sources decay below a minimum useful activity
without manual treatment, the P39 PSAs will be assembled with a Dallas
Semiconductor Smart Source EEPROM. This EEPROM contains enough memory to
store the measured activity and date of the source manufacture for each of the ten
point sources within a PSA.

Data encryption methods will be applied to the data

stored in the chip to allow error checking when reading the chip contents.
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DS2433
5

6

7

To CPSI
8

Figure 7.1. Block Diagram of Smart Source Board

The SSB will interface with the CPSI. The DHI will then communicate with the CPSI,
allowing interrogation of the Smart Source EEPROM. Firmware on the DH I will read
the contents of the EEPROM and make this data available to the Emission
Computerized Axial Tomography (ECAT) software. This will permit the capability of
automatic transmission source-strength correction as well as notification of the
operator when sources are nearing replacement time. The unique serial number in
each Smart Source chip permits source traceability for regulatory purposes.
Physically, the Smart Source EEPROM will be mounted on a small pc-board (SSB)
with a flexible cable terminated by a connector that will plug into a connector on the
CPSI.

Since the head of the SSB moves approximately one-half inch when the

source extends, a flexible cable is important.

7.2

Components
The Smart Source Board contains an EEPROM and a connector. The EEPROM is
described below.

7.2.1 Smart Source EEPROM
The Dallas Semiconductor Smart Source EEPROM is a self-contained electronic chip
that has a permanent unique serial number as well as 4k-bits of non-volatile memory.
The chip will be programmed by a PC interface at the time of source manufacture.
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Each Smart Source chip is loaded with the measured activity and date of source
manufacture for each of the ten point sources in the P39 point source assembly. An
8-pin, 4-kbit EEPROM (OS2433) will be used in this application. The EEPROM will
be programmed using a OS9097U-S09 serial port adapter and a modified OS14020OR8 blue dot receptor. The programming connector from the computer can be the
same type of connector used to connect the pc-board to the CPSI (OS2433 4k-Bit 1Wire™ EEPROM Data Sheet).

7.3

Risk Assessment & Hazard Analysis
A comprehensive Risk Assessment and Hazard Analysis will not be considered at this
level unless an assembly or subassembly analysis shows that it is warranted. High
voltage is not present on the board, and the OS2433 EEPROM is a low current
component. Therefore, there is essentially no risk associated with the SSB.

7.4

Initial Production, Verification, & Validation

7.4.1 Initial Production
Initial Production Units of the SSB will be built prior to Release to Production. These
units will be assembled by Benchmark Electronics. The Responsible Engineer will be
accountable for testing the units built prior to Release to Production.

All

documentation pertaining to assurance of these units' functionality will be retained in
the Smart Source design notebook. Changes to the initial design will be documented
in the P39 project notebook.

7.4.2 Verification
At least six units will be built first.

These units will be visually inspected for

consistency to the schematics and BOM. All power connections will then be checked
for shorts with an ohmmeter.

The unit will be powered on the bench, and desired

operation of all circuits will be verified and documented.
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7.4.3 Validation
The Smart Source board will be connected to a host processor such that correct read
and write operations may be verified by someone other than the responsible
engineer. Any problems encountered will be fixed before release.

7.5

Additional Requirements

7.5.1 Labeling & Packaging Requirements
All boards will have CTI part numbers, serial numbers, and revision levels clearly
marked. They will be handled and shipped according to the usual ESD precautions.

7.5.2 Environmental Limitations
The SSB will be enclosed in the gantry, which is sealed and environmentally
controlled.

7.5.3 Applicable Standards & Regulatory Requirements

7.6

•

European Union Medical Device Directive (MOD), 12 July 1993, 93/42/EEC.

•

Quality System Regulation, 21 CFR Part 820 Medical Devices; Current Good
Manufacturing Practice (CGMP).

•

ANSI/ASQC Q9001-1994 (ISO) Quality Systems Model for Quality Assurance in
Design, Development, Production, Installation, and Servicing.

•

IEC 601-1-4, Medical Electrical Equipment - General Requirements for Safety.

Cost Goal
Each Smart Source Board will cost approximately $50 to construct.
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7.7

Schedule
•

I

8

TASK
Develop the P39 Smart Source Board
Initial Specifications
Design
Schematics
Choose Parts/ Create BOM
Design Review
Verify Components/ Netlist
P39 Smart Source Board Layout
PCB PlacemenU Routing
PlacemenURouting Review
P39 Smart Source Board Verification
Verify two or three boards
Develop Validation/ Test Procedure
Develop the Windows programming software
Find/Design an Encryption/ Decryption Algorithm
Create GUI Framework
Add Programming functionality
TesU Debug
Develop DHI Firmware to Support the Smart Source Board

Duration (days)

17
2

5
4
4
1
1
3
2
1

7
2

5
22

5
2
10

5
20

Smart Source Testware
This section describes the P39 Smart Source test hardware and software, which are
used to store the source information in the Smart Source EEPROM. I developed the
Smart Source dialog interface software, which can be used with associated hardware
to quickly write an EEPROM and test it for proper operation.

8.1

Need for Product
PET scan operators must be able to determine when sources decay below a
minimum useful activity.

Therefore, the P39 PSA will be assembled with a Dallas

Semiconductor Smart Source EEPROM mounted to the SSB. While the EEPROM
contains sufficient memory to store activities and manufacture dates, both software
and hardware are needed to write the necessary information to the EEPROM. The
Smart Source information results in the capability of automatic transmission sourcestrength correction as well as notification of the operator when sources are nearing
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replacement time.

Ultimately, this interface allows a user to quickly write to an

EEPROM and to test whether or not the EEPROM is working properly.

8.2

Structure & Interfaces
As sources are generated in the laboratory, a software interface is needed to allow
technicians to enter the appropriate source data into the EEPROM.

This user

interface utilizes dialog boxes for simplicity and was constructed in Visual C++. An
example of the dialog interface is shown in Figure 8.2.
:f:t

EJ

Record of P39 Point Source Date and Strength

Date

I 8/10/01

Isotope

IGE68

Isotope Source

IDOE

Manuf acturer

JCTI

Assembly Serial No.

IABC789

Technician's First Name

JCINDY

Technician's Last Name

JJONES

3
3
3
3

[ 5t~us

Source Strength #1 (mCi)

11.23

Source Strength #2 (mCi)

12.34

Source Strength #3 (mCi)

J3.45

Source Strength #4 (mCi)

14.56

Source Strength #5 (mCi)

J5.67

Source Strength #6 (mCi)

J6.78

Source Strength #7 (mCij

17.89

Source Strength #8 (mCi)

18.90

Source Strength #9 (mCi)

19.01

Complete

I

E><it

Source Strength #10 (mCi) 110.00

Done.

II

I~

2

3

4

5

6

7

8

9

• • • • • • •

10

-I

Figure 8.2. User Dialog Interface

Also, if there are problems during or prior to writing, specific error messages appear
to help the user correct the problem. Once the user has entered valid information, the
interface encrypts the date and activity source data, and then writes the data to the
EEPROM with other general information.

This information is then read back, in

decrypted form, and verified before completion.

8.3

Hardware & Software
This section contains descriptions of the hardware and software components
associated with the Smart Source.
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8.3.1 Pentium PC with Windows 95,98, or 2000
This component is used both in the development of the interface software and in the
actual application of the interface software. The sources lab technician needs the PC
to execute the interface dialog software for writing to the EEPROM.

8.3.2 Microsoft Visual C++
Visual C++ and the Dallas Semiconductor Software Developer's Kit were used to
develop the code to read and write the Smart Source EEPROM.

The C++ code

provides the means to encrypt and download the desired source data into the
EEPROM and to test whether or not the EEPROM is working properly. Firmware on
the DHI utilizes the same decryption algorithm to correctly decode the data.

The

encryption/decryption code is used to encrypt and decrypt the data to be stored in the
EEPROM.

This algorithm employs a key, which will be unique for each device by

using certain combinations of the EEPROM serial number.

The method of key

generation is a secret among CTI's Research and Development engineers and is not
needed by the user (Jones).

(Due to a CTI confidentiality contract, further details

cannot be provided about the encryption code I wrote for Smart Source applications.)

8.3.3 DS2433 EEPROM
The Dallas Semiconductor Smart Source EEPROM is a self-contained electronic chip
that has a permanent unique serial number as well as 4k-bits of non-volatile memory.
The chip is programmed by a PC interface at the time of source manufacture. Each
Smart Source chip is loaded with the measured activity and date of source
manufacture for the ten point sources of the P39 PSA.

8.3.4 DS9097U-S09 Universal Serial Port Adapter
This adapter connects to the PC serial port and to a blue dot receptor. The adapter
enables a PC to directly read and write the 1-wire EEPROM (DS9097U-S09 Universal
Serial Port Adapter Data Sheet).

8.3.5 DS1402D-DR8 Blue Dot Receptor
This device contains an 8-foot coiled cable with two blue dot receptors on one end to
provide touch communication with an iButton™ EEPROM.
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The other end has a

RJ-11 connector to connect to the serial port adapter.

Since this receptor is

manufactured to support iButtonsTM, it will have to be slightly modified to provide
interface for non-metal can packaged EEPROMs.

This modification will be

documented so that it can be reproduced (OS14020-0R8 Blue Dot Receptor Data
Sheet).

8.4

Overview of EEPROM Storage

8.4.1 64-Bit Lasered ROM
Each OS2433 contains a unique ROM sequence that is 64 bits long. The first eight
bits are a 1-Wire family code, and the next 48 bits are a unique serial number. The
last eight bits are a Cyclic Redundancy Check (CRC) of the first 56 bits. The 1-Wire
CRC is generated using a polynomial generator conSisting of a shift register and
exclusive OR gates, modeled by the polynomial X8+X5+X4+1. The shift register bits
are initialized to zero. Then, starting with the least significant bit of the family code,
one bit at a time is shifted in. After the 8th bit of the family code has been entered,
then the serial number is entered. After the 48th bit of the serial number has been
entered, the shift register contains the 8-bit CRC value. This CRC value is verified by
an independent C++ calculation before writing to the EEPROM (Application Note 27 Understanding and Using Cyclic Redundancy Checks).

8.4.2 EEPROM Memory Map
The EEPROM contains a 32-byte page called the scratchpad and sixteen additional
32-byte pages called memory.

The OS2433 contains pages 0 through 15, which

compose the 4096-bit EEPROM memory. The scratch pad is an additional page that
acts as a buffer when writing to memory. For this application, only pages 0-6 store
data.

8.4.3 Universal Data Packet
The Universal Data Packet (UOP) is a structure used to store data on the EEPROM.
It includes 1-2 bytes representing the string length of the data it contains, followed by
the data string, and then two inverted CRC bytes. This CRC value is 16 bits, rather
than 8, and it is generated according to the standardized polynomial function
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X 16+ X 15+ X2+1.

In contrast to the 8-bit CRC, the 16-bit CRC is always returned or sent

in inverted form.
UOPs always start on page boundaries but can end anywhere. The first 1-2 bytes
representing string length contain the number of data bytes excluding the length
byte(s) and the CRC16 bytes. There is only one length byte when the number of data
bytes is less than 255 (always the case in this application). If there are 255 or more
data bytes, then the first length byte is 255 and the next length byte is 0 to 253. The
first and second length bytes added together provide the total number of data bytes.
The CRC16 is first initialized to the starting page number in order to verify that the
correct page is being read. The CRC16 is then calculated over the length and data
bytes. It is then inverted and stored low byte first followed by the high byte (OS2433
4k-Bit 1-Wire™ EEPROM Data Sheet).

8.4.4 Location of data in the EEPROM

** Specific encryption data has been omitted to protect confidentiality agreement with CTI. **

Page 0
Byte 0
Bytes 1-20
. Byte 21
Bytes 22-23
Bytes 24-31
I

I

Length of Identification String (including null character) = 21
Identification String CTI PET Systems Inc .
Null Character 0
16-bit CRC Value 6, 64
Empty

=

=

=

Page 1
i

Byte 0
Bytes 1-(x-1)
Byte x
Bytes (x+1) - (x+2)
Bytes (x+3) - 31
Page 2
Byte 0
Bytes 1-8
Byte 9
Bytes 10-14
Byte 15
Bytes 16-20
Byte 21
Bytes 22-26
Byte 27
Bytes 28-29
Bytes 30-31

Length of Serial Number String (including null character)
Serial Number String
Null Character 0
16-bit CRC Value
Empty

=x

=

Length of First Encrypted Source String (including null character)
Encrypted Data Set #1
Encrypted Character Divider
Encrypted Data Set #2
Encrypted Character Divider
Encrypted Data Set #3
Encrypted Character Divider
Encrypted Data Set #4
Null Character 0
16-bit CRC Value
Empty

=
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Page 3
Byte 0

Length of Second Encrypted Source String (including null character)
Encrypted Data Set #5
Encrypted Character Divider
Encrypted Data Set #6
Encrypted Character Divider
Encrypted Data Set #7
Encrypted Character Divider
Encrypted Data Set #8
Null Character 0
16-bit CRC Value
Empty

iytes 1-5
yte6
Bytes 7-11
Byte 12
Bytes 13-17
Byte 18
Bytes 19-23
Byte 24
Bytes 25-26
Bytes 27-31
Page 4
Byte 0
~ of Third Encrypted Source String (including null character)
Bytes 1-5
pted Data Set #9
Encrypted Character Divider
Byte 6
Bytes 7-11
Encrypted Data Set #10
Byte 12
Encrypted Character Divider
Bytes 13-17
Encrypted Data Set #11
Encrypted Character Divider
I Byte 18
Encrypted Data Set #12
; Bytes 19-21
Encrypted Character Divider
Byte 22
Bytes 23-26
Encrypted Data Set #13
I Byte 27
Null Character = 0
Bytes 28-29
16-bit CRC Value
Bytes 30-31
Empty
Page 5
Byte 0
Length of Combination Isotope String (including null character) = 21
Bytes 1-5
Isotope (stored as 5 bytes; empty bytes appear as space char.)
Space Character
Byte 6
Isotope Source (stored as 10 bytes; empty bytes appear as space char.)
Bytes 7-16
Byte 17
Space Character
Manufacturer (stored as 3 bytes; empty bytes appear as space char.)
Bytes 18-20
Null Character = 0
Byte 21
I Bytes 22-23
16-bit CRC Value
Bytes 24-31
Empty
Page 6
Length of Entire Encrypted Name String (including null character) = x
Byte 0
Encrypted Data Set #14 (length = y)
Bytes 1 - Y
Byte (y+1)
Encrypted Character Divider
Bytes (y+2) - (x-1)
Encrypted Data Set #15
Byte x
Null Character = 0
Bytes (x+1) - (x+2)
16-bit CRC Value
Bytes (x+3) - 31
Empty
I

I

-26-

8.5

Version Control & Validation

8.5.1 Version Control
Version control of this software is handled by PVCS version control software by
Merant. The PVCS currently in use is version 6.7. The first working version of the
software was stored using PVCS. Any modifications will be shown in the description
of the new PVCS version.

8.5.2 Validation
The Smart Source EEPROM will be connected to a host processor such that correct
read and write operations may be verified by someone other than the responsible
engineer. Any problems encountered will be fixed before release.

8.6

Schedule
TASK
Develop the Windows programming software
Find/Design an Encryptionl Decryption Algorithm
Create GUI Framework
Add Programming functionality
Test! Debug
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Duration (days)

22
5
2
10

5

9

Conclusion & Recommendations
My greatest learning experience and most significant contribution to CTI's P39
Project was the Smart Source Testware development. This task required me to write
programs in Microsoft Visual C++, a language I had never used prior to this project.
also learned to read and write EEPROMs for the first time.
My C++ programming efforts enabled CTI technicians to enter source data
into a dialog interface (shown in Figure 8.2).

The technician then clicks the

"Complete" button, and the program proceeds to check for errors in the submitted
data, improper connections between the PC and EEPROM, and failures of the
EEPROM itself.

If problems do arise prior to or during writing, specific error

messages appear to help the user correct the problem. When no errors are present,
the program encrypts the source and technician identification data, and then writes
the data to the EEPROM along with other necessary information. This information is
then decrypted and verified before completion.

The technician is notified when

writing is complete and successful.
The Smart Source Testware can be used for other applications in CTI PET
scanners as well. My code is well documented and can easily be modified for use in
new assignments with similar requirements.

Currently, the encryption/decryption

portion of the code is of particular relevance and value to other CTI products.
My experiences with CTI were exciting and beneficial to my education in
nuclear engineering.

Furthermore, the CTI employees were friendly and willing to

share their expertise.

I gained practical knowledge during this internship that far

surpassed any of my experiences during previous jobs or university courses. I would
definitely recommend that future engineering students take advantage of an
opportunity to work with CTI and its innovative PET technology.
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